EyePoint Pharmaceuticals Inc (NASDAQ:EYPT) price on Thursday, January 16, fall -5.46% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $7.27.
A look at the stock’s price movement, the close in the last trading session was $7.69, moving within a range at $7.25 and $8.19. The beta value (5-Year monthly) was 1.517. Turning to its 52-week performance, $30.99 and $6.90 were the 52-week high and 52-week low respectively. Overall, EYPT moved -2.55% over the past month.
EyePoint Pharmaceuticals Inc’s market cap currently stands at around $496.18 million, with investors looking forward to this quarter’s earnings report slated for in February.
The average forecast suggests down to a -21.42% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 42.51M, representing a -7.63% decline on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that EYPT is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
4 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 4 recommend EYPT as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
EYPT’s current price about -6.23% and -17.09% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 42.23, while 7-day volatility ratio is 11.03% and 8.43% in the 30-day chart. Further, EyePoint Pharmaceuticals Inc (EYPT) has a beta value of 1.52, and an average true range (ATR) of 0.69. Analysts have given the company’s stock an average 52-week price target of $22, forecast between a low of $22 and high of $22. Looking at the price targets, the low is -202.61% off current price level while to achieve the yearly target high, price needs to move -202.61%. Nonetheless, investors will most likely welcome a -202.61% jump to $22 which is the analysts’ median price.
If we refocus on EyePoint Pharmaceuticals Inc (NASDAQ:EYPT), historical trading data shows that trading volumes averaged 0.89 over the past 10 days and 977.65K over the past 3 months. The company’s latest data on shares outstanding shows there are 68.25 million shares.
The 9.41% of EyePoint Pharmaceuticals Inc’s shares are in the hands of company insiders while institutional holders own 81.76% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 10.34 million on 2024-12-31, giving us a short ratio of 11.39. The data shows that as of 2024-12-31 short interest in EyePoint Pharmaceuticals Inc (EYPT) stood at 1711.9999999999998 of shares outstanding, with shares short rising to 9.25 million registered in 2024-11-29. Current price change has pushed the stock -2.42% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the EYPT stock continues to rise going into the next quarter.
